General Information of the Compound
| Compound ID |
CP0439052
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1,4-Di[3beta-(4-thiophene-3-yl-phenyl)tropane-2beta-carbonylamino]benzene
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C44H46N4O2S2
|
||||||||||||||||||
| Molecular Weight |
727.012
|
||||||||||||||||||
| Canonical SMILES |
CN1C2CCC1[C@@H]([C@H](C2)c1ccc(cc1)-c1ccsc1)C(=O)Nc1ccc(NC(=O)[C@@H]2C3CCC(C[C@@H]2c2ccc(cc2)-c2ccsc2)N3C)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C44H46N4O2S2/c1-47-35-15-17-39(47)41(37(23-35)29-7-3-27(4-8-29)31-19-21-51-25-31)43(49)45-33-11-13-34(14-12-33)46-44(50)42-38(24-36-16-18-40(42)48(36)2)30-9-5-28(6-10-30)32-20-22-52-26-32/h3-14,19-22,25-26,35-42H,15-18,23-24H2,1-2H3,(H,45,49)(H,46,50)/t35?,36?,37-,38-,39?,40?,41-,42+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OWLDNNYJJFSQJU-LOKCHCMISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter